Clinical Trial Update: Carbamylation in Renal Disease-modulation With Amino Acid Therapy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating carbamylation in renal disease using amino acid therapy in patients with end-stage renal disease on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Amino acid therapy (amino acids)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: End Stage Renal Failure on Dialysis | EARLY_Phase 1 | Status: COMPLETED